The E3 ligase TRIM22 functions as a tumor suppressor in breast cancer by targeting CCS for proteasomal degradation to inhibit STAT3 signalingYunkai Yang, Yan Wang, Xinhui Hao et al.|Cancer Letters|2024Cited by 18
Anti-BCMA/CD19 CAR T cell therapy in patients with refractory generalized myasthenia gravis: a single-arm, phase 1 trialYong Zhang, Ming Shi, Jiang Cao et al.|EClinicalMedicine|2025Cited by 12